Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROP stock price vs INSP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at INSP's multiple
Needs INSP P/E.
Implied fair value · at ROP's multiple
Needs ROP P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ROP FY 2025 (ended Dec 31, 2025) · INSP FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROPER TECHNOLOGIES, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Inspire Medical Systems, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.50x
0.14x
Net debt / EBITDA
Leverage against operating earnings
3.08x
-2.98x
Cash and equivalents
Liquid reserves on the balance sheet
$297.40M
$308.27M
Total debt
Interest-bearing obligations outstanding
$10.01B
$112.36M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HONEYWELL INTERNATIONAL INC
ROP vs HON
EMERSON ELECTRIC CO
ROP vs EMR
Fortive Corp
ROP vs FTV
Keysight Technologies, Inc.
ROP vs KEYS
METTLER TOLEDO INTERNATIONAL INC/
ROP vs MTD
Vontier Corp
ROP vs VNT
BOSTON SCIENTIFIC CORP
ROP vs BSX
Medtronic plc
ROP vs MDT
ABBOTT LABORATORIES
ROP vs ABT
JOHNSON & JOHNSON
ROP vs JNJ
LivaNova PLC
ROP vs LIVN
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
